$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method for identifying or characterizing properties of polymeric units 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • G06F-019/00
출원번호 US-0356349 (2003-01-31)
발명자 / 주소
  • Venkataraman, Ganesh
  • Shriver, Zachary
  • Raman, Rahul
  • Sasisekharan, Ram
  • Keiser, Nishla
출원인 / 주소
  • Massachusetts Institute of Technology
대리인 / 주소
    Wolf, Greenfield &
인용정보 피인용 횟수 : 0  인용 특허 : 52

초록

The invention relates to methods of identifying and characterizing properties of polymers to provide information about the polymer such as the charge of the polymer, the number and types or characteristics of units of the polymer and the sequence of the polymers. The invention also relates to method

대표청구항

1. In a system including a database of values of properties of polymers of chemical units, a method for determining the composition of a sample polymer of chemical units having a known molecular length, comprising steps of:(A) selecting, from the database, candidate polymers of chemical units having

이 특허에 인용된 특허 (52)

  1. Shultz John William ; Lewis Martin K. ; Mandrekar Michelle ; Leippe Donna ; Smith ; Jr. Roderick R. ; Welch Roy, Analytical methods and materials for nucleic acid detection.
  2. Doutremepuich Christian Raymond,FRX ; Saudubray Francois Eugene Pierre Marie,FRX, Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applicatio.
  3. Kakkar Vijay V. (Bickley GB3) Scully Michael F. (Crays Hill GB3), Antithrombotic composition.
  4. Zimmermann Joseph ; Vlodavsky Israel,ILX ; Bennett Clark,CAX ; Danagher Pamela,CAX ; Broughton Richard,CAX, Attenuation of wound healing processes.
  5. Weitz Jeffrey I.,CAX ; Hirsh Jack,CAX ; Young Edward,CAX, Compositions and methods for inhibiting thrombogenesis.
  6. Venkataraman Ganesh (Somerville MA) Sasisekharan Viswanathan (Somerville MA) Sasisekharan Ram (Somerville MA) Bobba Ratnaleela (Somerville MA) Cooney Charles L. (Brookline MA) Langer Robert (Newton M, Computer-implemented process and computer system for estimating the three-dimensional shape of a ring-shaped molecule an.
  7. Yan Johnson F., Gene and protein representation, characterization and interpretation process.
  8. Findlay Valerie S. (Horsham) Kerry Roger (Horsham) Pay Graham F. (Patcham) Wallis Robert B. (Leechponds Hills) Butler Keith D. (Soreham-by-Sea GB2), Heparin and hirudin antidotal compositions and methods.
  9. Piani Silvano (Bologna ITX) Tamagnone Gianfranco (Casafecchio di Reno ITX) Alpino Raul R. (Bologna ITX) Milani Maria R. (Trebbo di Reno ITX) Fantuz Marinella (Bologna ITX), Heparin derivatives and process for their preparation.
  10. Langer Robert S. (Somerville MA) Linhardt Robert J. (Somerville MA) Cooney Charles L. (Brookline MA) Fitzgerald Gerald (York PA) Grant Arthur (Newton MA), Heparinase derived anticoagulants.
  11. Zimmermann Joseph J. (Elm Grove WI) Lewis N. Tracey (Brossard CAX) Heft Robert A. (Ville St. Laurent CAX), Heparinase free of an anticoagulant component from flavobacterium Heparinum.
  12. Sasisekharan Ramnath ; Moremen Kelley ; Cooney Charles L. ; Zimmermann Joseph J. ; Langer Robert S., Heparinase gene from flavobacterium heparinum.
  13. Morikawa Kiyoshi (Hinode JPX) Miyazono Hirofumi (Higashiyamato JPX) Maruyama Hiroshi (Higashiyamato JPX) Yoshida Keiichi (Higashimurayama JPX), Heparitinase, process for producing the same and bacteria producing the same.
  14. Zimmerman Joseph J. (Boston MA) Cooney Charles L. (Brookline MA), Large scale method for purification of high purity heparinase from flavobacterium heparinum.
  15. Foley Kevin M. (Franklin OH) Griffin Charles C. (Oxford OH) Amaya Eduardo (Monroe OH), Low molecular weight heparin derivatives having improved anti-Xa specificity.
  16. Griffin Charles C. (710 Melissa Dr. Oxford OH 45056) Foley Kevin M. (5757 Lynn St. Franklin OH 45005) Amaya Eduardo (811 Sands Ave. Monroe OH 45050), Low molecular weight heparin derivatives with improved permeability.
  17. Lormeau Jean-Claude (Maromme FRX) Petitou Maurice (Paris Cedex FRX) Choay Jean (Paris FRX), Low molecular weight heparins of regular structure, their preparation and their biological uses..
  18. Clapper David L., Method and implantable article for promoting endothelialization.
  19. Vincent P. Stanton, Jr. ; Jia Liu Wolfe ; Tomohiko Kawate ; Gregory L. Verdine, Method for analyzing polynucleotides.
  20. Holme Kevin R. ; Liang Weisheng ; Tyrrell David J. ; Shaklee Patrick N., Method for controlling O-desulfation of heparin.
  21. Venkataraman, Ganesh; Shriver, Zachary; Raman, Rahul; Sasisekharan, Ram; Keiser, Nishla, Method for indentifying or characterizing properties of polymeric units.
  22. Sasisekharan Ramnath (Arlington MA) Moses Marsha A. (Brookline MA) Nugent Matthew A. (Bedford MA) Cooney Charles L. (Brookline MA) Langer Robert S. (Newton MA), Method for inhibiting angiogenesis using heparinase.
  23. Sasisekharan Ramnath ; Moremen Kelley ; Cooney Charles I. ; Zimmermann Joseph J. ; Langer Robert S., Method for obtaining a modified heparinase gene.
  24. Zimmermann Joseph J. (Elm Grove WI) Lewis N. Tracey (Brossard CAX) Heft Robert A. (Ville St. Laurent CAX), Method for the enzymatic neutralization of heparin.
  25. Skubitz Amy P. N. ; Furcht Leo T. ; Balles Mark ; Gregerson Dale S. ; Agarwal Anita ; Wright Martha M. ; Murali Shobana, Method for treating conditions of the eye using polypeptides.
  26. Van Gorp Cornelius L. (Lebanon OH) Wolf Thomas M. (West Chester OH), Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions.
  27. Toback F. Gary (Chicago IL) Lieske John C. (Evanston IL), Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells.
  28. Biemann Klaus (Alton Bay NH) Juhasz Peter (Everett MA), Methods and products for mass spectrometric molecular weight determination of polyionic analytes employing polyionic rea.
  29. Klock John C., Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin.
  30. Cohen Irun R. (Herzliya ILX) Lider Ofer (Herzliya ILX) Hershkoviz Rami (Herzliya ILX), Methods of using low molecular weight heparins treatment of pathological processes.
  31. Luster Andrew ; Leder Philip, Modulation of endothelial cell proliferation with IP-10.
  32. Bergendal Karin H. L. (Danderyd SEX) Johansson Rolf A. (Huddinge SEX) Svahn Carl M. E. (Sollentuna SEX), Novel heparin derivatives.
  33. Su Hongsheng (Longueuil CAX) Blain Francoise (Mtl. CAX) Bennett Clark (Pierrefonds CAX) Gu Kangfu (D.D.O. CAX) Zimmermann Joseph (Elm Grove WI) Musil Roy (Carlsbad CA), Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium hepari.
  34. Su Hongsheng,CAX ; Blain Francoise,CAX ; Bennett Clark,CAX ; Gu Kangfu,CAX ; Zimmermann Joseph ; Musil Roy, Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum.
  35. Cristofori Manlio (Bologna ITX) Marchi Egidio (Casalecchio de Reno ITX) Rotini Leone G. (Bologna ITX), Pharmaceutical compositions containing orally absorbable glycosamimoglycans.
  36. Chen Chau-Chyun (Lexington MA) Barrera Michael (Oakdale MN) Ko Glen (Tokyo JPX) Osias Martine (Watertown MA) Ramamathan Sundaram (Lexington MA) Tremblay David (Cambridge MA), Polymer component characterization method and process simulation apparatus.
  37. Mooney, David J.; Bouhadir, Kamal H.; Wong, Wai Kung; Rowley, Jon A., Polymers containing polysaccharides such as alginates or modified alginates.
  38. Langer Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA) Flanagan Margaret M. (Somerset MA) Klein Michael D. (Ann Arbor MI, Process for neutralizing heparin.
  39. Fussi Fernando (Lesmo ITX), Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obt.
  40. Langer ; Jr. Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA), Process for producing heparinase.
  41. Langer ; Jr. Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA), Process for producing heparinase.
  42. Nielsen Jorgen I. (Farum DKX), Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight hepar.
  43. Tsilibary Photini-Effie C. (Minneapolis MN), Prosthetic devices coated with a polypeptide with type IV collagen activity.
  44. Covey Thomas R. ; Huang Eric ; Henion Jack, Protein sequencing by mass spectrometry.
  45. Sasisekharan Ramnath (Arlington MA) Lohse Daniel L. (Bryan TX) Cooney Charles L. (Brookline MA) Linhardt Robert J. (Iowa City IA) Langer Robert S. (Newton MA), Purification of heparinase I, II, and III from Flavobacterium heparinum.
  46. Sasisekharan Ramnath (Arlington MA) Lohse Daniel L. (Bryan TX) Cooney Charles L. (Brookline MA) Linhardt Robert J. (Iowa City IA) Langer Robert S. (Newton MA), Purification, composition and specificity of heparinase I, II, and III from flavobacterium heparinum.
  47. Branellec Jean-Franois (Mont Saint Aignan FRX) Espejo Jose (Bois Guillaume FRX) Picart Philippe (Rouen FRX), Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them.
  48. Godavarti Ranganathan ; Sasisekharan Ram ; Ernst Steffen,DKX ; Venkataraman Ganesh ; Cooney Charles L. ; Langer Robert, Rationally designed polysaccharide lyases derived from heparinase I.
  49. Conti Renato (Milan ITX) Casati Paolo (Milan ITX) Gorini Maria B. (Milan ITX) Maggi Antonio (Milan ITX), Supersulfated heparins.
  50. Rigoutsos Isidore ; Califano Andrea, System and method for confirmationally-flexible molecular identification.
  51. Fillit Howard M. ; Harpel Peter C., Test for the detection of anti-heparin antibodies.
  52. Holme Kevin R. ; Shaklee Patrick N. ; Ishihara Masayuki, Therapeutic methods of using O-desulfated heparin derivatives.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로